ADVERTISEMENT
As you might guess, there's no easy answer to this question. As with other types of epilepsy treatment, individual needs and responses vary enormously. The range of alternative therapies is also enormous. The National Center for Complementary and...
People are bombarded on television and in magazines by advertisements for new medicines. These advertisements are accompanied by pages of small print full of the results of clinical trials. The use of placebos in the clinical trials that help prove...
Juvenile myoclonic epilepsy (JME) is a common epilepsy syndrome, which occurs in 7% of all people with epilepsy. If correctly diagnosed, up to 90% of people with JME become seizure-free on a regimen of medication, usually Depakote (valproate)....
Juvenile myoclonic epilepsy (JME) is not considered a severe condition. If the seizures are not controlled by medication, the doctor may have doubts about the diagnosis, the adequacy of treatment, or about the patient's lifestyle or compliance with...
Pfizer Inc announced in late October, 2003, that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA), seeking approval for a new seizure medicine called pregabalin (pree-gab-uh-lin). Pregabalin has been...

Pages